Orly Efros: Excited to Share a Major Milestone From My PhD at the Weizmann Institute of Science
Orly Efros, Thrombosis and Hemostasis Senior Physician at Sheba Medical Center, Tel Hashomer, shared a post on LinkedIn:
“Excited to share a major milestone from my PhD at the Weizmann Institute of Science, guided by Prof. Liran Shlush.
In this study, we:
- Built a comprehensive atlas of 212,000+ endothelial cells across 23 human tissues to define vascular and tissue-specific programs.
- Isolated and profiled circulating endothelial cells (CECs) from 287 donors, showing that they originate from diverse vascular and tissue sources.
- Discovered that CECs display striking plasticity: dedifferentiating into a progenitor-like state in-vitro, but re-differentiating under Notch pathway modulation into angiogenic and mature endothelial phenotypes.
- Uncovered a previously unrecognized paraneoplastic effect in breast cancer, where contralateral normal tissue shows enrichment of angiogenic endothelial cells—suggesting systemic tumor-driven vascular remodeling.
Together, these findings provide a framework to trace endothelial identity, introduce CECs as a model for studying tumor-associated vascular reprogramming, and open avenues for new diagnostic and therapeutic strategies.
Grateful to my amazing collaborators from the Weizmann Institute and Sheba Medical Center, and to my mentor Prof. Liran Shlush! Dror Brook, Yotam Yaniv, Jacob Elkahal, Nili Furer, Gal Dadi, Hadas Naor, Nimrod Rappoport, Oren Milman, Merav Kedmi, Uriel Katz, Sigal Tavor, Adrian Duek, Elad Maor, Leonid Sternik, Nathali Kaushansky, Eldad Tzahor, Karina Yaniv, Liran Shlush”
Title: Deciphering the Origin and Plasticity of Circulating Endothelial Cells: A Model for Systemic Angiogenesis Programs in Health and Disease
Authors: Orly Efros, Dror Brook, Yotam Yaniv, Jacob Elkahal, Nili Furer, Gal Dadi, Hadas Naor, Nimrod Rappoport, Oren Milman, Merav Kedmi, Uriel Katz, Sigal Tavor, Adrian Duek, Elad Maor, Leonid Sternik, Nathali Kaushansky, Eldad Tzahor, Karina Yaniv, Liran Shlush

Check out our preprint on bioRxiv.
Stay infromed with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS